Point72 Asset Management, L.P. 13D and 13G filings for Cidara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 10:02 am Sale |
2023-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
Point72 Asset Management, L.P. | 62,511 1.400% |
-130,889 (-67.68%) |
Filing |
| 2023-02-14 4:23 pm Sale |
2022-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
Point72 Asset Management, L.P. | 193,400 5.400% |
-22,502 (-10.42%) |
Filing |
| 2022-02-14 4:41 pm Purchase |
2021-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
Point72 Asset Management, L.P. | 215,902 6.500% |
5,902 (+2.81%) |
Filing |
| 2021-10-14 5:12 pm Purchase |
2021-10-13 | 13G | Cidara Therapeutics, Inc. CDTX |
Point72 Asset Management, L.P. | 210,000 6.300% |
210,000 (New Position) |
Filing |